Sublobar Resection Versus Lobectomy for cT1N0M0 Non-small-cell Lung Cancer
NCT ID: NCT03108560
Last Updated: 2018-09-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
600 participants
INTERVENTIONAL
2017-04-18
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Sublobar and Lobectomy in Small (2 Cm or Less 0.5<CTR<1) Non-small Cell Lung Cancer: a Prospective, Multicenter Randomized Controlled Study
NCT06028412
Comparison of Segmentectomy Versus Lobectomy for Non-small Cell Lung Cancer ≤ 2 cm in the Middle Third of the Lung Field
NCT04944563
Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
NCT02288026
Surgical Treatment of Elderly Patients With cT1N0M0 Non-small Cell Lung Cancer Comparison Between Sublobar Resection and Lobectomy
NCT02360761
Factors Determine the Feasibility and Surgical Margin Quality of Sublobar Resection for Non-small Cell Lung Cancer?
NCT07005401
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sublobar group
Patients receive sublobar resection, including wedge resection and segmentectomy.
sublobar resection
Patients receive sublobar resection, which includes wedge resection and segmentectomy.
Lobectomy group
Patients receive lobectomy.
lobectomy
patients receive lobectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sublobar resection
Patients receive sublobar resection, which includes wedge resection and segmentectomy.
lobectomy
patients receive lobectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ground-glass opacity, ≤2cm, GGO≥25%
* eligible for both lobectomy and sublobar resection
* intraoperative pathology is minimally-invasive adenocarcinoma or invasive adenocarcinoma
* intraoperative pathology of biopsied station 10 lymph node is negative
Exclusion Criteria
* intraoperative pathology of biopsied station 10 lymph node is positive
* multiple GGOs, lesions other than dominant lesion are malignant or \>5mm
* history of thoracic surgery
* history of malignancy in recent 5 years
* unstable systemic disease
* patients with psychiatric disorders
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ruijin Hospital
OTHER
RenJi Hospital
OTHER
Fujian Medical University Union Hospital
OTHER
The Second Affiliated Hospital of Dalian Medical University
OTHER
First Affiliated Hospital of Wenzhou Medical University
OTHER
Ningbo No.2 Hospital
OTHER
Shanghai Zhongshan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Di Ge, MD
Role: STUDY_CHAIR
Fudan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai Zhongshan Hospital
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZSTS201701
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.